openPR Logo
Press release

Prostate Cancer - Pipeline Review, H1 2017

07-17-2017 02:59 PM CET | Health & Medicine

Press release from: Report Hive

Prostate Cancer

Prostate Cancer

Report Hive Market Research Released a New Research Report of 1845 pages on Title " Prostate Cancer - Pipeline Review, H1 2017 "with detailed Analysis, Forecast and Strategies.

Prostate Cancer - Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer - Pipeline Review, H1 2017, provides an overview of the Prostate Cancer (Oncology) pipeline landscape.

Prostate cancer is a form of cancer that affects men and starts off in the prostate gland. Prostate cancer usually occurs in older men. Symptoms include trouble urinating, decreased force in the stream of urine, blood in the urine, pain in the lower back, hips or thighs, bone pain and erectile dysfunction. Predisposing factors include age, family history and obesity. Treatment includes surgery, chemotherapy and radiation therapy.

Request Free Research Sample: https://www.reporthive.com/request-sample.php?id=931474

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Prostate Cancer - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Prostate Cancer (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Prostate Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Prostate Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 18, 98, 108, 6, 247, 35 and 4 respectively. Similarly, the Universities portfolio in Phase II, Phase I, Preclinical and Discovery stages comprises 11, 15, 58 and 20 molecules, respectively.

Prostate Cancer (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Prostate Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Prostate Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Prostate Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Prostate Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Prostate Cancer (Oncology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Prostate Cancer (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Prostate Cancer (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

Table of Contents 2
Introduction 13
Prostate Cancer - Overview 14
Prostate Cancer - Therapeutics Development 15
Prostate Cancer - Therapeutics Assessment 78
Prostate Cancer - Companies Involved in Therapeutics Development 113
Prostate Cancer - Drug Profiles 263
Prostate Cancer - Dormant Projects 1732
Prostate Cancer - Discontinued Products 1763
Prostate Cancer - Product Development Milestones 1774
Appendix 1784

Browse Full Report: https://www.reporthive.com/details/prostate-cancer-pipeline-review-h1-2017

Key questions answered in the report

· What will the market size and the growth rate be in 2021?
· What are the key factors driving the Prostate Cancer Market?
· What are the key market trends impacting the growth of the Prostate Cancer Market?
· What are the challenges to market growth?
· Who are the key vendors in this market space?
· What are the market opportunities and threats faced by the vendors in the Prostate Cancer Market?
· Trending factors influencing the market shares of the Americas, APAC, and EMEA?
· What are the key outcomes of the five forces analysis of the Prostate Cancer Market?

We are a leading repository of market research reports and solutions catering to industries like Comm & Technology, Energy & Power, Food And Beverages, Automotive & Transportation, Healthcare & Life Science etc. This large collection of reports assists organizations in decision-making on aspects such as market entry strategies, market sizing, market share analysis, competitive analysis, product portfolio analysis and opportunity analysis among others. We also assist in determining the best suited and targeted report from our large repository of global reports, company-specific reports and country-level reports.

Mike Ross
Marketing Manager
mike.ross@reporthive.com
http://www.reporthive.com
Phone: +1 312-604-7084
Sainath Nagar, Vadgaon Sheri,
Pune, Maharashtra 411014

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prostate Cancer - Pipeline Review, H1 2017 here

News-ID: 627668 • Views: 142

More Releases from Report Hive

Corporate Performance Management (CPM) Software Market 2019: By Adaptive Insight …
According to this study, over the next five years the Corporate Performance Management (CPM) Software market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$ xx million in 2017. In particular, this report presents the global revenue market share of key companies in Corporate Performance Management (CPM) Software business, shared in Chapter 3. This report presents a comprehensive
Investment Management Solutions Market 2019: Misys, SS&C Tech, SimCorp, Eze Soft …
According to this study, over the next five years the Investment Management Solutions market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$ xx million in 2017. In particular, this report presents the global revenue market share of key companies in Investment Management Solutions business, shared in Chapter 3. This report presents a comprehensive overview, market shares and
Social Customer Service Software Market 2019: Zendesk, Salesforce, Freshworks, S …
According to this study, over the next five years the Social Customer Service Software market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2017. In particular, this report presents the global revenue market share of key companies in Social Customer Service Software business, shared in Chapter 3. This report presents a comprehensive overview, market
Auto Loan Origination Software Market 2019: DH Corp, Lending QB, Black Knight, I …
According to this study, over the next five years the Auto Loan Origination Software market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$ xx million in 2017. In particular, this report presents the global revenue market share of key companies in Auto Loan Origination Software business, shared in Chapter 3. This report presents a comprehensive overview, market

All 5 Releases


More Releases for Prostate

Global Prostate Cancer Therapeutics Market
Global Prostate Cancer Therapeutics Market – Industry Analysis and Forecast (2018-2026) –By Product Type, End User, and Region. Global Prostate Cancer Therapeutics Market was valued at US$ 9.21 Bn in 2017 and is expected to reach US$ 16.21 Bn by 2026, at a CAGR of 7.33 % during a forecast period. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,
Prostate Cancer Drugs Market Research Report 2018
This report studies the global Prostate Cancer Drugs market status and forecast, categorizes the global Prostate Cancer Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-prostate-cancer-drugs-2018-337 The major manufacturers covered in this report AbbVie Astellas Pharma Astra Zeneca Johnson & Johnson Sanofi GlaxoSmithKline Merck Group Novartis Amgen Bayer HealthCare Ferring Pharmaceutical Janssen Pharmaceuticals Endo Pharmaceuticals BMS Takeda
Prostate Biopsy Forceps Market
Global Prostate Biopsy Forceps Market Status and Trend Report offers a comprehensive analysis on Prostate Biopsy Forceps industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Browse Full Report with TOC: http://orbisresearch.com/contacts/request-sample/2072536 Key questions answered by this report include: Worldwide and Regional Market Size of Prostate Biopsy Forceps 2013-2017,
US Prostate Cancer Drug Pipeline Analysis
Prostate cancer has emerged as one of the most commonly diagnosed cancer among men in the US. According to the American Cancer Society, there were close to 242,000 new cases of prostate cancer in the US in 2012, with 28,000 men dying from it. This was an increase from 206,640 men diagnosed with the condition during 2009. The number of men being actively treated for prostrate disorders such as benign
Global Prostate Biopsy Market 2017-2021
Biopsy is a clinical procedure primarily used in the detection and extraction of malignant or cancerous cells and their abnormal growth in the body for further analysis and interpretation of diseases. The purpose of removing tissues or cells during the procedure is mainly to limit the spread of tumor, minimize morbidity, and eliminate interference with future treatments. Technavios analysts forecast the global prostate biopsy market to grow at a CAGR of
Prostate Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Prostate Cancer - Heat Map and Analysis to its growing collection of premium market research reports. Prostate cancer (PC) is a type of cancer that affects the prostate gland of the male reproductive system, and is the most common non-cutaneous malignant cancer in men. Internationally, it is the sixth-largest cancer-related cause of death in men. Those aged over 50 are